Orkla Q2 2025 presentation: Organic growth accelerates amid portfolio restructuring

Norwegian consumer goods giant Orkla ASA reported accelerating organic growth of 3.8% in Q2 2025, a significant improvement from Q1's 1.2%, signaling positive momentum from its ongoing portfolio restructuring strategy. While operating revenues increased 5% and reported profit surged due to one-off items, underlying EBIT grew a more modest 2.5% amidst mixed segment performance, with strong gains in Home & Personal Care and Snacks offset by declines in Food Ingredients. Despite maintaining ambitious long-term financial targets, the company noted a decline in cash flow from operations year-to-date, suggesting continued operational focus will be critical.

Analysis

Orkla ASA's Q2 2025 results signal that its portfolio restructuring is beginning to deliver on top-line growth, with organic growth accelerating to 3.8% from a sluggish 1.2% in Q1. While operating revenues grew 5% year-over-year to NOK 17,650 million, the underlying profitability tells a more nuanced story. Adjusted EBIT increased by a modest 2.5% and adjusted EPS was nearly flat with 0.6% growth, indicating margin pressure despite operational efficiency gains that saw the rolling 12-month EBIT margin improve to 10.3%. The dramatic surge in reported net profit to NOK 6,367 million is heavily distorted by one-off items, likely from the divestment of its Hydro Power and Pierre Robert Group assets. Performance across the portfolio is highly divergent; strong EBIT growth in Home & Personal Care (+20%) and Snacks (+13%) was counteracted by a significant decline in Food Ingredients (-21%) and a minor dip in its Jotun investment. A key point of concern is the deterioration in cash flow from operations, which declined to NOK 2.4 billion year-to-date from NOK 2.8 billion in the prior year, suggesting a disconnect between revenue growth and cash generation. While the company maintains its ambitious 2026 targets, including an 8-10% EBIT CAGR, achieving them will hinge on successfully turning around underperforming segments and addressing this cash flow weakness.

Key Decisions for Investors

• Investors should view Orkla as a strategic turnaround play, where the key driver is the successful execution of its portfolio restructuring, rather than broad-based organic growth across all segments.
• Closely monitor cash flow from operations in the next quarterly report on October 29, as the current decline despite revenue growth is a significant red flag that could signal underlying operational issues.
• Future performance will likely be driven by specific catalysts, such as the potential IPO of Orkla India and the US market entry for the Snacks division, which must be weighed against headwinds in the Food Ingredients and Health segments.
• Given the nearly flat adjusted EPS growth, investors should critically assess whether the stock's 44% return over the past year already reflects the anticipated benefits of the restructuring, or if execution risk is being underpriced.